Previous close | 0.4740 |
Open | 0.4894 |
Bid | 0.4900 x 3200 |
Ask | 0.5300 x 800 |
Day's range | 0.4737 - 0.5400 |
52-week range | 0.4510 - 4.3500 |
Volume | |
Avg. volume | 105,019 |
Market cap | 12.598M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.5920 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Infobird Co., Ltd (NASDAQ: IFBD) ("Infobird" or the "Company"), a leading provider of AI-powered customer engagement solutions in China, today announced that it has started to provide services to a leading global pharmaceutical and vaccine manufacturer's subsidiary with operations in China. Under this cooperation, Infobird will leverage its AI Chatbots and experience in the healthcare industry to provide dedicated support for the client's digital and intelligent customer engagement initiative de
BEIJING, June 21, 2022 /PRNewswire/ – Infobird Co., Ltd (NASDAQ: IFBD) ("Infobird" or the "Company"), a leading provider of AI-powered customer engagement solutions in China, today announced that it has entered into a cooperation agreement with a leading global Fintech service provider. Under this agreement, Infobird will leverage its AI Chatbots and years of experience in the financial industry to provide strong support for the client's digital and intelligent customer engagement. The cooperati
Infobird Co., Ltd (NASDAQ: IFBD) ("Infobird" or the "Company"), a leading provider of AI-powered customer engagement solutions in China, today announced that it aims to transform how dental practices engage with patients throughout the whole customer journey. Infobird's provides software solutions that digitize and improve existing customer engagement processes that are core to many medical practices and allows medical professionals to focus their efforts on providing high quality health care, r